BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27287229)

  • 1. Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
    Xu Z; Gwin KA; Li Y; Medina KL
    BMC Immunol; 2016 Jun; 17(1):16. PubMed ID: 27287229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors.
    Dolence JJ; Gwin KA; Shapiro MB; Medina KL
    Exp Hematol; 2014 May; 42(5):380-393.e3. PubMed ID: 24444745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
    Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
    Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the Pim1 kinase gene is a direct target of HOXA9.
    Hu YL; Passegué E; Fong S; Largman C; Lawrence HJ
    Blood; 2007 Jun; 109(11):4732-8. PubMed ID: 17327400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.
    Grundler R; Brault L; Gasser C; Bullock AN; Dechow T; Woetzel S; Pogacic V; Villa A; Ehret S; Berridge G; Spoo A; Dierks C; Biondi A; Knapp S; Duyster J; Schwaller J
    J Exp Med; 2009 Aug; 206(9):1957-70. PubMed ID: 19687226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment.
    Ceredig R; Rauch M; Balciunaite G; Rolink AG
    Blood; 2006 Aug; 108(4):1216-22. PubMed ID: 16675711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.
    Domen J; van der Lugt NM; Acton D; Laird PW; Linders K; Berns A
    J Exp Med; 1993 Nov; 178(5):1665-73. PubMed ID: 8228813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion.
    Thorsteinsdottir U; Mamo A; Kroon E; Jerome L; Bijl J; Lawrence HJ; Humphries K; Sauvageau G
    Blood; 2002 Jan; 99(1):121-9. PubMed ID: 11756161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
    Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
    J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo.
    Karsunky H; Merad M; Cozzio A; Weissman IL; Manz MG
    J Exp Med; 2003 Jul; 198(2):305-13. PubMed ID: 12874263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice.
    Tagaya H; Kunisada T; Yamazaki H; Yamane T; Tokuhisa T; Wagner EF; Sudo T; Shultz LD; Hayashi SI
    Blood; 2000 Jun; 95(11):3363-70. PubMed ID: 10828017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.
    McKenna HJ; Stocking KL; Miller RE; Brasel K; De Smedt T; Maraskovsky E; Maliszewski CR; Lynch DH; Smith J; Pulendran B; Roux ER; Teepe M; Lyman SD; Peschon JJ
    Blood; 2000 Jun; 95(11):3489-97. PubMed ID: 10828034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.
    Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK
    J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
    J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis.
    Lawrence HJ; Helgason CD; Sauvageau G; Fong S; Izon DJ; Humphries RK; Largman C
    Blood; 1997 Mar; 89(6):1922-30. PubMed ID: 9058712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
    Hu YL; Fong S; Ferrell C; Largman C; Shen WF
    Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
    Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
    Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of B lymphopoiesis at a lymphoid progenitor stage in adult rabbits.
    Kalis SL; Zhai SK; Yam PC; Witte PL; Knight KL
    Int Immunol; 2007 Jun; 19(6):801-11. PubMed ID: 17502309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.